Remove Dosage Remove FDA Remove Workshop
article thumbnail

Aseptic Conference Provides Solutions to Pharmaceutical Challenges

ISPE

Blow-fill-seal containers are commonly used for various dosage forms, what are the latest developments in this field? Project RiskSurve from FDA: a project to create a comprehensive site surveillance model consolidating data from different dimensions: what are the first learnings? What does KAIZEN for aseptic processing look like?

Dosage 98
article thumbnail

News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive

The FDA Law Blog

Brevig, Senior Regulatory Device and Biologics Expert — In January 2023, FDA published a paper summarizing its lessons learned from two pilot Quality Management Maturity (QMM) Pilot Programs, such as best practices for conducting QMM assessments and developing the QMM scoring system.

FDA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Semaglutide and Tirzepatide Resources for Independent Pharmacies

DiversifyRx

Compounding laws and regulations are a patchwork of rules and guidelines created by the FDA, USP, and state boards of pharmacy. While states can create their own rules, according to FDA guidelines, semaglutide and tirzepatide can be compounding because they are on the FDA shortage list. There is no need to rush to higher doses.

article thumbnail

Advancements & Innovations in Decontamination and Single-Use Technology

ISPE

The opening keynote will feature Brook Higgins from the FDA and focus on the critical role of environmental monitoring and preventative steps to take for a strong sterility assurance program to reduce positive sterility tests. The conference will have a highly anticipated industry panel solely focusing on the revisions to Annex 1.

Dosage 52
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting.” Review: Continuous Manufacturing of Small Molecule Solid Oral Dosage Forms.” Advanced Manufacturing.”

article thumbnail

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence

ISPE

Its Pharmaceutical Education & Research Center (PERC) is a US Food and Drug Administration (FDA)-registered, cGMP-compliant, single-source CRO equipped with the latest equipment and technologies, for most dosage forms, found in the pharmaceutical industry. 2 Research Triangle Park. As automation and Pharma 4.0

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

USA The FDA established the Emerging Technology Program (ETP) in 2014 and has actively promoted the program 8. A final report will be provided as the basis for an ISPE workshop, with recommendations subsequently published in Pharmaceutical Engineering and other trade publications. 22 June 2023. link] 16 US Food and Drug Administration.

FDA 52